TSLA · Tesla, Inc.
10-Q filed 2026-07-23 period 2026-06-30
76 Stable
confidence high · source filing on SEC.gov ↗
- Capital expenditures surged to $8.28 billion for the first half of 2026, with full-year 2026 CapEx expected to exceed $25 billion driven by AI and compute infrastructure investments.
- Tesla launched and began production of the Cybercab, shifting the business model towards service-driven real-world AI and autonomous Robotaxi networks.
- Completed a $2.00 billion related-party equity investment in SpaceX common stock during the six months ended June 30, 2026.
vs. prior filing (10-Q filed 2026-04-23) — ⚠ ALERT
FHS 82 → 76 (-6) · Strong -> Stable
Profitability -15Balance sheet -5Cash generation -10Risk flags +5Mgmt signal -3
Filing Health Score pillars
Profitability 25%
70
According to the Results of Operations section, total revenues grew 26% YoY to $28.24 billion in Q2 2026, but operating income fell to $398 million from $923 million due to a 49% increase in R&D and a 45% increase in SG&A expenses.
Balance sheet 20%
85
As shown in the Consolidated Balance Sheets, Tesla maintains a strong liquidity position with $43.52 billion in cash and short-term investments against total debt of $9.34 billion, though outstanding shares increased by 5.3% to 3,949 million.
Cash generation 20%
65
According to the Summary of Cash Flows, operating cash flow of $8.63 billion significantly exceeded net income of $1.62 billion for the six-month period, but high CapEx of $8.28 billion reduced free cash flow to $352 million.
Risk flags 20%
85
Based on the Controls and Procedures and Note 13 sections, there are no material control weaknesses or going-concern doubts, though risks include ongoing litigation expenses and a $2.00 billion related-party investment in SpaceX.
Mgmt signal 15%
75
In the MD&A Outlook section, management signals a heavy pivot toward AI, robotics, and autonomous driving, forecasting 2026 CapEx to exceed $25 billion, which will negatively impact near-term profitability.
Key metrics (Six Months Ended June 30, 2026)
period: Six Months Ended June 30, 2026
total debt: $9,342 million
cash and equivalents: $15,219 million
shares outstanding: 3,949 million
revenue: $50,623 million
net income: $1,619 million
operating cash flow: $8,634 million
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.